Inherently electroactive graphene oxide nanoplatelets as labels for single nucleotide polymorphism detection.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 22992186.
- Also identified by DOI 10.1021/nn301359y.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Graphene materials are being widely used in electrochemistry due to their versatility and excellent properties as platforms for biosensing. However, no records show the use of inherent redox properties of graphene oxide as a label for detection. Here for the first time we used graphene oxide nanoplatelets (GONPs) as electroactive labels for DNA analysis. The working signal comes from the reduction of the oxygen-containing groups present on the surface of GONPs. The different ability of the graphene oxide nanoplatelets to conjugate to DNA hybrids obtained with complementary, noncomplementary, and one-mismatch sequences allows the discrimination of single-nucleotide polymorphism correlated with Alzheimer's disease. We believe that our findings are very important to open a new route in the use of graphene oxide in electrochemistry.
Medical subject headings
- Alzheimer Disease
- Biosensing Techniques
- Conductometry
- DNA Mutational Analysis
- Graphite
- Nanoparticles
- Polymorphism, Single Nucleotide